Your browser doesn't support javascript.
loading
Modeling Kaempferol as a Potential Pharmacological Agent for COVID-19/PF Co-Occurrence Based on Bioinformatics and System Pharmacological Tools.
Jiang, Yong; Xie, Yi-Zi; Peng, Chen-Wen; Yao, Kai-Nan; Lin, Xue-Ying; Zhan, Shao-Feng; Zhuang, Hong-Fa; Huang, Hui-Ting; Liu, Xiao-Hong; Huang, Xiu-Fang; Li, Hang.
Affiliation
  • Jiang Y; Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, China.
  • Xie YZ; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Peng CW; The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Yao KN; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Lin XY; The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Zhan SF; Shenzhen Bao'an District Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China.
  • Zhuang HF; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Huang HT; The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Liu XH; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Huang XF; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Li H; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Front Pharmacol ; 13: 865097, 2022.
Article in En | MEDLINE | ID: mdl-35754492
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: China